D016259Genes & Molecular SequencesG05.360.340.024.340.375.500.791.420660.998797Genes, mycFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation Resourcevivo:orcidIdORCID idPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson21109931Regan PL, Jacobs J, Wang G, Torres J, Edo R, Friedmann J, Tang XXInternational journal of oncologyHsp90 inhibition increases p53 expression and destabilizes MYCN and MYC in neuroblastoma. Int J Oncol. 2011 Jan; 38(1):105-12.Int J Oncol2011-01-01T00:00:002011Hsp90 inhibition increases p53 expression and destabilizes MYCN and MYC in neuroblastoma.0.06733510.01683386research area of0.6298410.05168696subject area fortrue1ProfessorProfessorPediatricsKatalinMikeczKatalin Mikecz41.87352120000000-87.66713820000000349080Mikecz, KatalinProfessorNarineHakobyanNarine Hakobyan349102Hakobyan, NarineAssistant ProfessorAmarjitVirdiAmarjit Virdi349707Virdi, AmarjitProfessor6Assistant Professor4Professortrue1ProfessorProfessor15172967Hakobyan N, Kazarian T, Jabbar AA, Jabbar KJ, Valentino LABloodPathobiology of hemophilic synovitis I: overexpression of mdm2 oncogene. Blood. 2004 Oct 01; 104(7):2060-4.Blood2004-06-01T00:00:002004Pathobiology of hemophilic synovitis I: overexpression of mdm2 oncogene.15866420Sena K, Leven RM, Mazhar K, Sumner DR, Virdi ASUltrasound in medicine & biologyEarly gene response to low-intensity pulsed ultrasound in rat osteoblastic cells. Ultrasound Med Biol. 2005 May; 31(5):703-8.Ultrasound Med Biol2005-05-01T00:00:002005Early gene response to low-intensity pulsed ultrasound in rat osteoblastic cells.Orthopedic SurgeryAnatomy and Cell BiologyRush University, Rush Medical CollegeJoshuaJacobsJoshua J. Jacobs41.87352120000000-87.66713820000000349020Jacobs, Joshua0000-0003-3902-7334ProfessorDale (Rick)SumnerDale (Rick) Sumner41.87328300000000-87.66936330000000349028Sumner, Dale (Rick)0000-0001-9575-3862Professortrue1ProfessorProfessortrue1ProfessorProfessor27469075Landsburg DJ, Falkiewicz MK, Petrich AM, Chu BA, Behdad A, Li S, Medeiros LJ, Cassaday RD, Reddy NM, Bast MA, Vose JM, Kruczek KR, Smith SE, Patel P, Hernandez-Ilizaliturri F, Karmali R, Rajguru S, Yang DT, Maly JJ, Blum KA, Zhao W, Vanslambrouck C, Nabhan CBritish journal of haematologySole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable. Br J Haematol. 2016 Nov; 175(4):631-640.Br J Haematol2016-07-29T00:00:002016Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable.true1Assistant ProfessorAssistant Professor28749548Epperla N, Maddocks KJ, Salhab M, Chavez JC, Reddy N, Karmali R, Umyarova E, Bachanova V, Costa C, Glenn M, Calzada O, Xavier AC, Zhou Z, Hossain NM, Hernandez-Ilizaliturri FJ, Al-Mansour Z, Barta SK, Chhabra S, Lansigan F, Mehta A, Jaglal MV, Evens AM, Flowers CR, Cohen JB, Fenske TS, Hamadani M, Costa LJCancerC-MYC-positive relapsed and refractory, diffuse large B-cell lymphoma: Impact of additional "hits" and outcomes with subsequent therapy. Cancer. 2017 11 15; 123(22):4411-4418.Cancer2017-07-27T00:00:002017C-MYC-positive relapsed and refractory, diffuse large B-cell lymphoma: Impact of additional "hits" and outcomes with subsequent therapy.